About Hyogo Prefectural HarimaHimeji General Medical Center
兵庫県立姫路循環器病センターは、兵庫県姫路市にあった県立病院。1981年に日本で初めての循環器専門の自治体病院として開設され、当初より心臓血管病と脳血管障害を二本柱とした診療を行っていた。臨床研修病院の指定を受けるほか、兵庫県災害拠点病院、救急告示医療機関などの指定を受けていた。
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Hyogo Prefectural HarimaHimeji General Medical Center
During the past decade, Hyogo Prefectural HarimaHimeji General Medical Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Adaptive Phase II Study to Evaluate the Safety & Efficacy of NaBen®
2014-06-01
2023-12-31
Recruiting
126
Efficacy, Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
2015-07-23
2019-02-27
Completed
387
Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia
2016-07-25
2020-01-29
Completed
509
This Study Tests Whether BI 409306 Prevents Patients With a Specific Type of Mental Illness (Attenuated Psychosis Syndrome) From Becoming Worse. This Study Looks at How Well Patients Tolerate the Medicine and How Effective it is Over 1 Year
2017-09-29
2021-04-07
Terminated
50
Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia
2017-07-20
2019-02-05
Terminated
119
This Study Tests Whether BI 409306 Prevents Patients With Schizophrenia From Becoming Worse. This Study Looks at How Well Patients Tolerate BI 409306 and How Effective it is Over 6 Months
2017-12-07
2021-03-31
Terminated
264
A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication
2018-07-13
2019-10-21
Completed
233
A Study to Assess the Effects of RO6889450 (Ralmitaront) in Participants With Schizophrenia or Schizoaffective Disorder and Negative Symptoms
2018-12-04
2023-12-29
Active, not recruiting
128
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Hyogo Prefectural HarimaHimeji General Medical Center
According to Clinical.Site data, the most researched conditions in "Hyogo Prefectural HarimaHimeji General Medical Center" are
"Alzheimer Disease" (2 trials). Many other conditions were trialed in "Hyogo Prefectural HarimaHimeji General Medical Center" in a lesser frequency.
Clinical Trials Intervention Types at Hyogo Prefectural HarimaHimeji General Medical Center
Most popular intervention types in "Hyogo Prefectural HarimaHimeji General Medical Center" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Gantenerumab" (2 trials) and "Placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hyogo Prefectural HarimaHimeji General Medical Center
The vast majority of trials in "Hyogo Prefectural HarimaHimeji General Medical Center" are
2 trials for "All" genders.
Clinical Trials Status at Hyogo Prefectural HarimaHimeji General Medical Center
Currently, there are NaN active trials in "Hyogo Prefectural HarimaHimeji General Medical Center".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Hyogo Prefectural HarimaHimeji General Medical Center,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Hyogo Prefectural HarimaHimeji General Medical Center, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".